Bringing 3D cardiac tissues to high throughput for drug discovery screens

Informazioni relative al progetto

3DCardiacHTS

ID dell’accordo di sovvenzione: 101099000

DOI

10.3030/101099000

Progetto chiuso

Data della firma CE 26 Ottobre 2022

Data di avvio 1 Gennaio 2023

Data di completamento 30 Novembre 2025

Finanziato da

• The European Innovation Council (EIC)

Costo totale

€ 1 457 500,00

Contributo UE

€ 1 457 500,00

Coordinato da

RIVER BIOMEDICS B.V.
Netherlands

CORDIS fornisce collegamenti ai risultati finali pubblici e alle pubblicazioni dei progetti ORIZZONTE.

I link ai risultati e alle pubblicazioni dei progetti del 7° PQ, così come i link ad alcuni tipi di risultati specifici come dataset e software, sono recuperati dinamicamente da .OpenAIRE .

Risultati finali

Documents, reports (3)

Dataset on high throughput integration and validation

Together with our partner we will generate a dataset on running our 3DCardiacHTS technology in the high throughput setup of our partner, integration and validation of the technology

Dissemination and exploitation plan 2

Execution on dissemination and exploitation by filing patents and presenting in conferences.

Functional fluidic circuit board

We will generate a functional fluidic circuit board that can drive flow to multiple different locations on the board.

Websites, patent fillings, videos etc. (2)

Dissemination and exploitation plan 1

Execution on dissemination and exploitation by filing patents and presenting in conferences.

Website and logo

Have a website and logo dedicated for this project.

Data sets, microdata, etc (1)

Dataset with contractile responses to each drug

We will test a list of 20 drugs, known to have an effect in the human heart, on the 3D cardiac strips and generate a dataset with contractile responses to each drug.

Data Management Plan (1)

Data Management Plan

Delivery of data management plan (DMP), Tech to market and dissemination and exploitation plan